News and Comments

SAREPTA: What's Going On ?

  Tuesday, April 16, 2013

The requests Sarepta Therapeutics (SRPT) has gotten from the FDA represent a sign of FDA seriousness towards bringing the firm’s drug eteplirsen for Duchenne muscular dystrophy as soon as possible to the children suffering from the debilitating, fast deteriorating disease. The FDA did not wait for the firm to file for early approval, it rather asked Sarepta to bring in more data that would legitimize granting early approval of the first drug ever to claim treating the disabling disease at its root-origin. Investors who should have been optimistic about the FDA initiative sold their shares instead, causing them to lose around 10% of their value.  More...

ImmunoGen Offers New Hopes For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Difficult-To-Treat Cancers

  Friday, April 12, 2013

 More...

A Quick Response To ARIAD'S (ARIA) Conference Call

  Thursday, April 04, 2013

 More...


Recent Postings


Archive


Tags

Auspex (ASPX) Intercept (ICPT) Human Genome Sciences (HGSI) Xoma (XOMA) Alnylam (ALNY) ARCA (ABIO) Telaprevir Inovio (INO) TOKAI (TKAOI) Ziofpharm (ZIOP) Ridaforolimus Sanofi-Aventis (SAN) C4 Therapeutics Onyx (ONXX) Anacor (ANAC) Abbott Laboratories (ABT) Regeneron (REGN) Exelixis (EXEL) ISIS (ISIS) GUARDIAN HEALTH Ocular Therapeutix (OCUL) BIOMARIN (BMRN) GlaxoSmithKline (GSK) Amgen (AMGN) Tysabri Valeant Pharmaceuticals International (VRX) Revlimid (lenolidamide) Editas (EDIT) Sequenom (SQNM) Agenus (AGEN AstraZeneca (AZN) SYNTA (SNTA) Biogen Idec (BIIB) KERYX (KERX) Ariad (ARIA) SUNESIS PHARMACEUTICALS (SNSS) Aimmune Therapeutics (AIMT) Adaptimmune (ADAP) Biocryst (BCRX) Spike Therapeutics (ONCE) MODERNA CEMPRA (CEMP) AGOS (ARGS) Sanofi (SNA) ZALTRAP™ CompuGen (CGEN) Prolor Biotech (PBTH) Herceptin Cytokinetics (CYTK) Micromet (MITI) NOVOCURE (NVCR) OSI (OSIP) Advaxis (ADXS) Incyte (INCY) Trastuzumab-DM1 Intermune (ITMN) ADVENTRIX (ANX) NEKTAR (NKTR)) Mirati Therapeutics (MRTX) Elan (ELN) Idenix (IDIX) Velcade (bortezomib) Array Pharmaceuticals (ARRY) Jazz Pharmaceuticals (JAZZ) Illumina (ILMN) PTC Therapeutics (PTCT) AERIE PHARMACEUTICALS Merck (MRK) Dendreon (DNDN) Pluristem (PSTI) Gilead (GILD) ACADIA (ACAD) Benlysta (belimumab) INNOVIVA (INVA) Prosensa (RNA) Genentech Alder Biopharmaceuticals (ALDR) REGULUS (RGLS) ARGOS (ARGS) Sangamo (SGMO) ABBVIE (ABBV) Agenus (AGEN) Human Longevity (HLI) Intrexon (XON) Bristol-Myers Squibb (BMY) Sanofi (SNY) HALOZYME (HALO) Ionis (IONS) ImmunoGen (IMGN) Anadys (ANDS) RenenxBio (RGNX) Zerenex Global Cell Therapeutics (GBT) IDERA (IDRA) Bellicum (BLCM) KITE (KITE) Seattle Genetics (SGEN) Multiple Myeloma Roche (ROCHE) Roche (RHHBY) Dynavax (DVAX) Rapamune Endometrial Cancer Theravance (THRX) Vitae Pharmaceuticals (VTAE) SERES THERAPEUTICS (MCRB) Vertex (VRTX) JUNO (JUNO) Theravance Bio Pharma (TBPH) galapagos (GLPG) VANDA (VNDA) NANTKWEST (NK) Galena (GALE) Sarepta (SRPT) CRISPR Therapeutics (CRSP)